Metastasis: Clinical and Experimental Aspects: Developments in Oncology, cartea 4
Editat de Kurt Hellmann, P. Hilgard, Suzanne A. Ecclesen Limba Engleză Paperback – 13 ian 2013
Din seria Developments in Oncology
- 5% Preț: 353.45 lei
- 5% Preț: 377.07 lei
- 5% Preț: 345.71 lei
- 5% Preț: 1074.75 lei
- 5% Preț: 353.62 lei
- 5% Preț: 1103.07 lei
- 5% Preț: 3118.93 lei
- 5% Preț: 363.85 lei
- 5% Preț: 367.04 lei
- 5% Preț: 1389.15 lei
- 5% Preț: 367.79 lei
- 5% Preț: 361.17 lei
- 5% Preț: 1079.77 lei
- 5% Preț: 360.97 lei
- 15% Preț: 592.33 lei
- 5% Preț: 1396.84 lei
- 5% Preț: 1096.43 lei
- 5% Preț: 367.04 lei
- 5% Preț: 1387.38 lei
- 5% Preț: 708.59 lei
- 5% Preț: 698.91 lei
- 5% Preț: 1395.26 lei
- 5% Preț: 704.13 lei
- 5% Preț: 360.26 lei
- 5% Preț: 1394.36 lei
- 5% Preț: 1075.45 lei
- 5% Preț: 3758.19 lei
- 5% Preț: 1078.35 lei
- 5% Preț: 1086.60 lei
- 5% Preț: 1390.62 lei
- 5% Preț: 1410.11 lei
- 5% Preț: 1092.13 lei
Preț: 371.71 lei
Preț vechi: 391.27 lei
-5% Nou
Puncte Express: 558
Preț estimativ în valută:
71.14€ • 73.89$ • 59.09£
71.14€ • 73.89$ • 59.09£
Carte tipărită la comandă
Livrare economică 01-15 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789400989276
ISBN-10: 940098927X
Pagini: 492
Ilustrații: XXXIV, 456 p.
Dimensiuni: 155 x 235 x 26 mm
Greutate: 0.68 kg
Ediția:Softcover reprint of the original 1st ed. 1980
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Oncology
Locul publicării:Dordrecht, Netherlands
ISBN-10: 940098927X
Pagini: 492
Ilustrații: XXXIV, 456 p.
Dimensiuni: 155 x 235 x 26 mm
Greutate: 0.68 kg
Ediția:Softcover reprint of the original 1st ed. 1980
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Oncology
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
The Significance of Metastases to the Surgeon.- The Spread of Rectal Cancer into Veins and the Mechanism of Distant Embolism.- Squamous Carcinomas of the Head & Neck: Patterns and Mechanisms of Local Invasion and Metastasis.- The Relationship between Malignant Melanoma Morphology, Metastases and Patient Survival.- Animal Tumour Models: The Intrusion of Artefacts.- Models of Prostate, Breast, Lung and Intestinal Carcinomas which Metastasize in Rats.- A New In-Vitro Model to Study Tumour Cell Invasion.- Invasiveness and the “Metastatic Potential” of Tumour Cells.- A Possibility of Predicting the Metastatic Potential of Tumours by Implantation into Chick Embryo Blastoderms.- An Experimental Study on the Barrier Function of Lymph Nodes to Tumor Cells.- Metastases from DMBA-Induced Carcinomas in Hamster Cheek Pouch.- Quantitation and Cellular Growth of Occult Metastases of a Rat Mammary Carcinoma.- Comparison of Natural and Artificial Lung Metastases from a Murine Tumour of Spontaneous Origin.- Growth Inhibition of Simulated Metastases by a Large Primary Tumor.- Quantitative Studies on Metastasis using Yoshida Rat Ascites Hepatomas, with Special Reference to the Biological Characteristics in Metastasizability and Drug Sensitivity.- Canine Osteosarcoma and Canine Mammary Carcinoma.- Selection of a Human Malignant Melanoma X Hamster Hybrid Cell Line by Metastasis.- Morphological Aspects of the Interaction of Blood Coagulation and Tumour Dissemination.- Cancer Cell Procoagulant Activity, Warfarin and Experimental Metastases.- Molecular Mechanism of Fibrinolysis and its Potential Role in Metastasis.- Fibrinolysis and Anticoagulation in Colo-Rectal Cancer — The Way Ahead.- Studies on Factors Influencing the Lodgement of Circulating Tumour Cells.- Critical Analysis ofExperimental Models for the Antimetastatic Effects of Anticoagulants.- Effect of Fibrinolysis Inhibition on the Growth and Hematogenous Dissemination of Cancer.- Mechanisms Behind the Inhibiting Effect of Tranexamic Acid on Tumour Growth and Spread.- The Inhibitory Effect of Sulfated Polysaccharides, Ancrod or Tranexamic Acid on Pulmonary Metastases in Animals.- Prostacyclin as a Marker for Diagnosing and Staging Carcinoma of the Prostate.- Prostaglandins and Metastasis.- The Application of a Defibrinogenating Snake Venom Enzyme in Experimental Tumor Metastasis.- Effect of Ticlopidine on Blood-Borne Metastasis.- Failure of RA233 to Affect the Growth of Intravenously Injected Murine Lymphoma Cells.- Failure of Flurbiprofen to Affect the Metastasis of Rodent Sarcomas.- In Vivo and In Vitro Selection of Experimental Metastatic Variants of Rodent Melanoma, Mammary Carcinoma and Lymphosarcoma.- The Role of Tumor Cell-Basement Membrane Interactions in the Metastatic Process.- Morphological and Biochemical Differences of Primary and Metastatic Human Melanoma Cells.- Lewis Lung Carcinoma: Selecting Metastatic Variants.- Malignant Properties of Clones Isolated from a Mouse Fibrosarcoma.- Characteristics of Tumor Cell Clones with Varying Malignant Potential.- Invasion of Lung and Liver Tissue by Different Types of Tumour Cells.- Interactions of Tumor Cells with Isolated Hepatocytes. A Model for the Infiltration of Blood-Borne Tumor Cells in the Liver.- Ultrastructural Features of Intravascular and Extravascular Migration of Cancer Cells.- Characteristics of Metastasizing and Non-Metastasizing Tumors and their Interaction with the Host Immune System in the Development of Metastasis.- Metastatic Potential of Tumor Cells from Spontaneous Metastasis.- Cell Surface Changes Associatedwith the Selection of Spontaneous Metastases.- Intrinsic and Extrinsic Factors Governing the Expression of Metastatic Potential.- Metastatic Potential of SK-Br-3 Cells Treated with L-Cysteine or Ascorbic Acid.- Effect of Pre-Treatment with Antisera Against Choriogonadotropin on the Metastatic Potential of a Rat Adenocarcinoma.- Metastases of Mammary Tumours in BR6 Mice.- Fixation of ?-Melanocyte Stimulating Hormone (?-MSH) to Human Metastatic Melanoma Cells In Vitro and In Vivo.- Metastases of Human Tumours in the Nude Mouse: The Behaviour of Colon Carcinoma Xenografts.- Immune Regression of Metastases Following Hyperthermic Treatment of Primary Tumours.- Clonal Tumor Cell Variants Arising by Adaptation.- Reversibility of Immunological and Antitumoral Effects Produced In Vivo by Particulate ?l–3 Glucans.- Modulation of Tumor Growth and Metastasis by an Acute Inflammation.- Enhancement of Pulmonary Metastases Induced in Mice by Cyclophosphamide: Role of the Immune System.- Antimetastatic Effects of Intrapleurally Injected Corynebacterium Parvum.- Does C. Parvum Treatment Affect Tumour Blood Flow and Hence Metastasis?.- Reticuloendothelial System Function in Cancer Patients Treated with C. Parvum.- Inhibition of Pulmonary Metastasis of Lewis Lung Tumor by Nocardia Rubra-Cell Wall Skeleton or Schizophyllan.- Minimal Residual Disease may be Treated by Chessboard Vaccination with Vibrio Cholerae Neuraminidase (VCN) and Tumor Cells.- Application of the Leukocyte Migration Test (LMT) To Patients with Metastases: Evidence in Favour of a Change in Host Response?.- Computed Tomography in the Staging of Malignancy.- Serial Quantitative Skeletal Scintigraphy in Breast Cancer.- Further Studies on the Effect of Prostaglandin Synthesis Inhibitors and Diphosphonates onTumour-Mediated Osteolysis.- Potential Clinical Use of Diphosphonates against Bone Metastases and Hypercalcaemia of Malignancy.- Multiparametric Biochemical Study in the Diagnosis of Bone Metastasis of Breast Cancer.- Acute Changes in Calcitonin Levels in Lung Cancer Patients Treated with C. Parvum: Do these Reflect In Vivo Killing of Tumour Cells?.- Serial Quantitative Bone Scanning of Metastatic Tumour in Rats.- Experimental Study on Characteristics of Microcirculation in Tumor Tissue, with Reference to Cancer Chemotherapy.- Development of Severe Radiation Pheumonitis in Patients with Oat Cell Carcinoma during Combined Modality Therapy.- Effect of Hemithorax Irradiation of Young Mice on Pulmonary Metastatic Deposits from Subsequently Developing Spontaneous Mammary Tumours.- The Chemotherapy of Micrometastases — An Overview of Current Status.- Adjuvant Razoxane in Resectable Colorectal Cancer.- Changing Aspects in the Surgical Approach to Metastatic Disease; Influence of Chemotherapy on Indications For and Results Of Metastasectomies.- Clinical Study on Selective Enhancement of Drug Delivery by Angiotensin II in Cancer Chemotherapy.- Differences and Similarities in Adjuvant Chemo-Therapy in Mouse and Man.- Drug Response of Two Different In Vitro Tumour Lines Derived from Lung Metastases of 3LL.- Therapeutic Implications of Heterogeneous Tumor Cell Populations.- Effect of Bleomycin Scheduling on Lung Metastases of 3LL and a Subline of Different Metastatic Potential.- Metastasis of Lewis Lung Carcinoma (LL) Regrowing After Cytotoxic Treatments.- Adjuvant Chemotherapy Following Surgery for Small-Cell Carcinoma of the Lung.- Cell Surface Sialylation of Metastatic Variant Murine Tumor Cell Lines.- Potential for Selective Inhibition of Metastasis.- Tumour Load DependentEffectiveness of Cyclophosphamide in Lewis Lung Carcinoma.- Prophylactic Antimetastatic Agents: Dimethyltriazenes, N-Diazoacetylglicine Derivatives and other Neutral Proteinase Inhibitors.- Selective Chemotherapy of Metastasis by Drug Carrying Fat Emulsion or Tumor Specific Antibody.- Treatment of Metastases in Long Bones.- Immunotherapy as Adjuvant Treatment for Residual Tumors.